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ABSTRACT  22 
We report that several viruses from the human enterovirus group B cause massive vimentin 23 
rearrangements during lytic infection. Comprehensive studies suggested that viral protein 24 
synthesis was triggering the vimentin rearrangements. Blocking the host cell vimentin 25 
dynamics with IDPN did not significantly affect the production of progeny viruses and only 26 
moderately lowered the synthesis of structural proteins such as VP1. In contrast, the 27 
synthesis of the non-structural proteins 2A, 3C, and 3D was drastically lowered. This led to 28 
attenuation of the cleavage of the host cell substrates PABP and G3BP1 and reduced 29 
caspase activation, thus leading to prolonged cell survival. Furthermore, the localization of 30 
the proteins differed in the infected cells. Capsid protein VP1 was found diffusely around 31 
the cytoplasm, whereas 2A and 3D followed vimentin distribution. Based on protein 32 
blotting, lower amounts of non-structural proteins did not result from proteasomal 33 
degradation, but from lower synthesis without intact vimentin cage structure. In contrast, 34 
inhibition of Hsp90 chaperone activity, which regulates P1 maturation, lowered the amount 35 
of VP1, but had less effect on 2A. The results suggest that, the vimentin dynamics regulate 36 
viral non-structural protein synthesis while having no effect on structural protein synthesis 37 
or overall infection efficiency. The results presented here shed new light on differential fate 38 
of structural and non-structural proteins of enteroviruses, having consequences on host cell 39 
survival.  40 
 41 
  42 
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Importance 43 
A virus needs the host cell in order to replicate and produce new progeny viruses. For this, 44 
the virus takes over the host cell and modifies it to become a factory for viral proteins. 45 
Irrespective of the specific virus family, these proteins can be divided into structural and 46 
non-structural proteins. Structural proteins are the building blocks for the new progeny 47 
virions, whereas the non-structural proteins orchestrate the take-over of the host cell and 48 
its functions. Here we have shown a mechanism that viruses exploit in order to regulate the 49 
host cell. We show that viral protein synthesis induces vimentin cages, which promote 50 
production of specific viral proteins that eventually control apoptosis and the host cell 51 
death. This study specifies vimentin as the key regulator of these events and indicates that 52 
viral proteins have different fates in the cells depending on their association with vimentin 53 
cages. 54 
 55 
 56 
  57 
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INTRODUCTION 58 
Human enteroviruses (EVs) are a large group of viruses including rhinoviruses, echoviruses, 59 
group A and B Coxsackieviruses, and polioviruses. They are among the most common 60 
viruses infecting humans worldwide. Most commonly, EV’-s cause acute infections, leading 61 
to lytic cell death with rapid clearance of the virus by the immune system (1). However, in 62 
some cells, infection can become persistent and lead to chronic infection (2). Deciphering 63 
the cellular events during viral infection is the key for understanding the consequences and 64 
pathology of virus infections. 65 
 66 
Enteroviruses have four structural (VP1 to VP4) proteins that form the icosahedral virus 67 
capsid and ten non-structural (2A, 2B, 2C, 2BC, 3A, 3B, 3AB, 3C, 3D and 3CD) proteins, with 68 
several different functions. Enteroviral protease 2A cleaves the cellular eukaryotic 69 
translation initiation factor 4 G (eIF4G), poly A binding protein (PABP), controls apoptosis 70 
and induces stress granule formation (3-6). Protease 3C cleaves the cellular Ras GTPase-71 
activating protein-binding protein 1 (G3BP1) and PABP (4, 6, 7). Protein 3D is an RNA-72 
dependent polymerase and has been shown to be involved in the inflammatory response via 73 
the activation of NLRP3 inflammasome (8). All the viral proteins are processed from one 74 
single polyprotein and viral protein processing has been shown to be cellular chaperone 75 
mediated (9-11).  76 
 77 
Vimentin is the most common intermediate filament in several cell types. Its expression is 78 
altered during development and in certain diseases. Vimentin has a high degree of similarity 79 
among species, suggesting that it plays a vital role in normal cellular functions. Several 80 
research groups have reported the spatial association of vimentin with viruses during 81 
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infection, particularly near the replication area and progeny virus production (12-34). 82 
Despite the abundance of such reports, there is still no consensus on the role played by 83 
vimentin during virus infections. In addition, the mechanisms by which the virus triggers 84 
vimentin remodeling remains undefined. In addition to virus infections, vimentin is 85 
associated with several significant human diseases. During cancer development, vimentin 86 
expression correlates with tumor growth, invasiveness, and poor prognosis. In addition to its 87 
structural role, vimentin has been shown to function as a key regulator of organelle 88 
positioning (35), cell migration, adhesion, and cell signaling (36).  89 
 90 
In our earlier studies, we noticed that the morphology of the cellular vimentin network 91 
correlated with echovirus-1 (EV-1) infection efficiency in tested human cell lines (14). 92 
Changes in vimentin network brought about with different media and treatments correlated 93 
with successful baculovirus transduction and echovirus infection, suggesting that vimentin 94 
network has a previously unknown role in infection. Here we hypothesized that, in highly 95 
permissive cells, virus could modify vimentin network for its own benefits most likely via 96 
cellular stress processes that it has been shown to regulate. Here we have tested this 97 
hypothesis with careful monitoring of cellular vimentin network and several vimentin 98 
related stress responses throughout EV infection. 99 
We show that infection by a member of the human EV group B viruses leads to massive 100 
rearrangements of the intermediate filament, vimentin. When vimentin dynamics are 101 
inhibited, expression of the viral non-structural proteins is affected, the cellular targets of 102 
2A and 3C, PABP and G3BP1, remain uncleaved and cell death is postponed. In contrast, VP1 103 
expression is only slightly decreased and infective progeny viruses are being produced. Our 104 
data here suggest that vimentin network plays a regulatory role in viral non-structural 105 
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protein expression, contributing to host cell survival, whereas the soluble pool of structural 106 
proteins remain largely unaffected by vimentin dynamics.  107 
 108 
RESULTS 109 
Human EV infection induces drastic vimentin rearrangements that start appearing by the 110 
time of replication and contain dsRNA 111 
In order to determine the role of vimentin during EV infection, A549 cells were infected with 112 
Coxsackievirus B3 (CVB3), fixed at different time points post infection (p.i.), and 113 
immunolabeled for virus progeny capsids (VP1) and vimentin. When the composition of the 114 
vimentin network was thoroughly analyzed using confocal microscopy, it was noticed that at 115 
later stages of infection, when the cytoplasm was full of newly synthetized capsid proteins 116 
(4 to 6 h post infection (p.i.)), the majority of the infected cells showed drastic vimentin 117 
rearrangements leading to the formation of a compact vimentin cage next to the nucleus 118 
(Fig. 1A). Furthermore, tubulin labeling was done in order to ensure that the whole 119 
cytoskeleton was not affected in infected cells (Fig 1B). Cells infected with EV1, 120 
Coxsackievirus B1 (CVB1), and Coxsackie A9 virus (CVA9) showed similar vimentin 121 
rearrangements in the late stages of their lifecycle (Fig. 1C). The vimentin modifications 122 
were only seen in infected cells, indicating that these were virus-induced (Fig. 1A, C; 123 
uninfected cells shown by asterisks). Capsid protein VP1 was diffusely scattered all around 124 
the cytoplasm and on the cell edges, whereas the virus-induced vimentin structure was 125 
compact and formed in the perinuclear area (Fig. 1A, C).  126 
We next took a look at the association between the replication intermediate dsRNA and 127 
vimentin using an antibody against double-stranded RNA (dsRNA) to mark the cells positive 128 
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for virus replication. It was noticed that vimentin formed a compartment that surrounded 129 
the dsRNA (Fig. 1D). A time course study showed that dsRNA and vimentin rearrangements 130 
both appeared around 3 to 4 h p.i. and became more pronounced during the progression of 131 
infection (Fig. 1E). Vimentin rearrangements started by first forming thicker filaments in the 132 
periphery of the cell leaving the perinuclear area, where dsRNA can usually be seen, devoid 133 
of vimentin. Then, slowly, as the signal for dsRNA increased, a thick vimentin “barrier” 134 
started to decrease in diameter and eventually, around 5 h p.i., it became a round 135 
compartment that contained dsRNA within. However, even if vimentin was accumulating in 136 
the perinuclear area, it did not drastically change the cell size or overall morphology, which 137 
was visible from the cell outlines marked in the images (Fig. 1E). As cells were still attached 138 
to the coverslips, these images verify that the vimentin structures were not formed simply 139 
due to cell rounding and detachment.  140 
We then set out to quantify the relative amounts of cells positive for capsid protein 141 
production, to evaluate the intensity of VP1 label in the cells, to quantify the number of 142 
infected cells showing virus-induced vimentin compartments and cells positive for viral 143 
replication (dsRNA), to measure the intensity of dsRNA label in the cells, and to assess the 144 
frequency of dsRNA enwrapped by the vimentin structure during the later time points (3 to 145 
6 h p.i.) (Fig. 2A, B). Altogether, the results showed that at 3 h p.i. around 20 percent of the 146 
cells were positive for newly-synthetized VP1 and 60 percent were positive for dsRNA. 147 
However, both the dsRNA and capsid levels per cell were still extremely low, indicating that 148 
the replication had just started. From the cells positive for progeny virus production, only 20 149 
percent showed the typical virus-induced vimentin rearrangements at 3 h p.i. However, as 150 
the relative amount of capsids per infected cell started to increase after 4 h p.i., so did the 151 
appearance of virus-induced vimentin structures, leading to almost 80 percent of the 152 
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infected cells with vimentin compartments surrounding dsRNA. It was clear from the 153 
quantification that both dsRNA appearance and capsid protein synthesis started before the 154 
virus-induced vimentin compartments started appearing. This suggests that vimentin 155 
structure formation is not needed to initiate virus replication. Instead, the emergence of 156 
dsRNA or viral proteins could act as a trigger for the vimentin rearrangements to take place.  157 
 158 
Vimentin dynamics are triggered by the emergence of viral proteins  159 
We then set out to define the trigger for the virus-induced changes in vimentin distribution 160 
and structure. To determine whether virus internalization was sufficient, or whether later 161 
stages of the virus lifecycle, such as uncoating and/or replication, were needed for the virus-162 
induced vimentin rearrangements to take place, two approaches, neutral-red viruses and 163 
UV-inactivated viruses, were used.  164 
First, we tested neutral red-labeled CVB3-viruses (NR-CVB3), which are photosensitive and 165 
can be light inactivated resulting in uncoating-deficient viruses (Fig. 3A). Cells infected with 166 
NR-CVB3 were either kept in the dark (ctrl) or exposed to light at different time points p.i. 167 
After ten minutes of light treatment at RT, the cells were incubated at 37 °C until 5 h p.i. 168 
after which cells were fixed and immunolabeled for virus capsid and vimentin. These results 169 
showed that photo-inactivated NR-CVB3 viruses were not able to induce the vimentin 170 
rearrangements if the inactivation was performed prior to 3 h p.i., i.e. before replication had 171 
taken place. When the light inactivation was performed from 3 h p.i. onwards, virus-induced 172 
vimentin structures started appearing (Fig. 3A). Light inactivation itself did not alter 173 
vimentin network. Light-inactivation at 0 h p.i. totally prevented virus infection as 174 
determined by end-point-titration, confirming that the light inactivation was working 175 
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correctly (data not shown).  Furthermore, NR-CVB3 kept in the dark showed high infectivity 176 
(2.18 x 108 pfu/ml) also confirming the functionality of the NR-virus.  177 
In addition to the NR-CVB3 experiment, the effect of UV-inactivated EV1 (UV-EV1) viruses 178 
were tested (Fig. 3B). Cells were infected either with the wt-EV1 or with the UV-inactivated 179 
EV1, fixed at 5 h p.i. and immunolabeled to visualize EV1 capsids and vimentin. As the 180 
results show, UV-inactivated viruses were not able to cause the typical virus-induced 181 
vimentin structures that can be seen surrounding the viral dsRNA in infected control cells. 182 
These results thus suggested that mere internalization and intracellular/endosomal 183 
presence of virus is not enough to trigger the vimentin changes. 184 
Next, we determined whether the genome itself could act as a trigger for the vimentin 185 
rearrangements or whether replication and/or protein synthesis was needed. We tested the 186 
effects of cycloheximide and puromycin on cells, which have earlier been shown to inhibit 187 
poliovirus protein synthesis (37). Our results showed that these treatments prevented virus-188 
induced CPE (Fig. 3C), vimentin rearrangements (Fig. 3D), and CVB3 infection as determined 189 
by VP1 expression (Fig. 3E). We also confirmed an efficient inhibition of replication by 190 
quantifying the (-) and (+) strand synthesis by qPCR (Fig. 3F). In order to arrest replication by 191 
other means, we tested guanidine hydrochloride (GuHCl). GuHCl has been shown to inhibit 192 
enteroviral 2C protein leading to inhibition of the initiation of negative strand RNA synthesis 193 
(38-40). Our results showed that addition of 2 mM GuHCl in early infection completely 194 
inhibited virus infection, also the protein production detected by immunolabeling of VP1 195 
protein (data not shown). Subsequently, also vimentin cages did not form. Although the 196 
inhibitor should not impair translation per se, it understandably has consequences on 197 
silencing infection in general due to the block of replication. To further study the role of 198 
replicating dsRNA, we transfected the cells with low and high concentrations of the dsRNA 199 
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analog Poly-IC and monitored vimentin dynamics. The results showed that transfection of 200 
Poly-IC into cells did not cause vimentin rearrangements (data not shown). This suggests 201 
that the cellular machinery recognizing foreign dsRNA does not trigger the events leading to 202 
vimentin dynamics during infection.  203 
Heat shock proteins (Hsp’s) and Hsp70 in particular, have been associated with several virus 204 
infections such as rabies (41) and dengue (42). Hsp90 was previously shown to be essential 205 
for the viral assembly and capsid production of Enterovirus 71 (43) and poliovirus (44) by 206 
protecting the viral components from proteasomal degradation. Also here we wanted to 207 
determine whether Hsp70 and Hsp90 had any role in vimentin dynamics during infection. To 208 
accomplish this, we used the specific inhibitor of Hsp70, VER155008, which is known to bind 209 
to the ATP-binding site of Hsp70 and to prevent substrate binding and chaperone activity. In 210 
addition, we used the Hsp90 inhibitor geldanamycin. Hsp70 and Hsp90 work in collaboration 211 
in cells so that Hsp90 receives its client proteins from hsp70 in a partially folded state. 212 
Although proteins from the Hsp family are also associated with cellular stress and survival, 213 
the inhibitors used here act only on the chaperone activity. First, we monitored the cell 214 
viability in response to VER155008 and geldanamycin. Both Hsp inhibitors were able to 215 
postpone virus-induced cell death, while VER155008 was more potent in its effect (Fig. 3G). 216 
In addition to preventing cell death, these inhibitors blocked or decreased the vimentin cage 217 
formation (Fig. 3H). This also correlated with the decrease of infectivity in total, as 218 
determined by dsRNA appearance in the infected cell cytoplasm (Fig. 3I) and VP1 expression 219 
in the cells (Fig. 3J).  220 
Altogether, these results indicate that viral protein synthesis is dependent on functional 221 
chaperones, especially Hsp70, and that viral protein expression is essential for the vimentin 222 
structures to form. 223 
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Inhibiting vimentin dynamics delays host cell death while allowing efficient infection  224 
Vimentin is the most common intermediate filament, but there is a shortage of drugs and 225 
treatments that can be used to modify its functions. In previous vimentin-related 226 
publications, acrylamide and calyculin A have been used to inhibit vimentin dynamics, but in 227 
our experiments with A549 cells, the recommended concentrations of these compounds led 228 
to rapid cell death (data not shown). We were also unsuccessful in completely knocking 229 
down vimentin using a siRNA approach (data not shown). Another drug that has been 230 
shown to lead to the disruption of vimentin is β, β′-Iminodipropionitrile (IDPN) (45). IDPN 231 
was found gentle enough to cause only a slight decrease in cell viability during our 232 
experimental setup in A549 cells (Fig. 4A). In addition, IDPN treatment did not induce any 233 
vimentin changes by itself (Fig. 4B). Remarkably, cells infected in the presence of IDPN were 234 
not showing signs of virus induced CPE, and cell viability remained high even 8 hp.i., 235 
whereas in control infection, already over 80 % of the infected cells had died (Fig. 4C). 236 
Strikingly, this did not correlate with progeny virus production as, indeed, IDPN treated cells 237 
efficiently produced infective virions similar to control cells as was judged by end-point 238 
titration (Fig. 4D). Also, only a slight decrease in replication was observed, based on the 239 
measurement of (+) strand synthesis using qPCR in IDPN treated cells (Fig. 4E). This was also 240 
confirmed by labeling of dsRNA (Fig. 4F). IDPN did however have a clear effect on the 241 
localization of dsRNA, as it spread out to a wider area in the cytoplasm from the perinuclear 242 
area when formation of vimentin cages was prevented with IDPN.   243 
 244 
The location of viral non-structural proteins 3D and 2A follow the location of vimentin in 245 
the cells, whereas VP1 localization was not affected by changes in vimentin 246 
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We were then curious to monitor the expression of individual viral, both structural and non-247 
structural proteins. Confocal microscopy of 3D polymerase showed a notable decrease in 3D 248 
expression under IDPN treatment in comparison to normal infection (Fig. 5A). In addition, 249 
the localization of the 3D signal was quite well associated with vimentin cages, whereas 250 
during IDPN treatment, the signal was spread out in the cell, similar to vimentin label. In 251 
addition to 3D, 2A protease showed a similar phenomenon (Fig. 5B). It associated more 252 
strongly with the vimentin cage during infection but spread out to all cytoplasm showing 253 
lower signal during IDPN treatment (Fig. 5B). In contrast to these results with non-structural 254 
proteins, VP1 label seemed to be similarly strong during normal infection and IDPN 255 
treatment (Fig. 5C). Also, there was no apparent shift in the location of the signal due to 256 
IDPN treatment, suggesting that the structural and non-structural proteins may be 257 
differentially located during their translation in the cytoplasm with respect to vimentin 258 
distribution. This led us to evaluate the location of other cellular components, whether their 259 
location would be sensitive to IDPN treatment. Indeed, the luminal ER marker PDI was 260 
spread out during IDPN treatment, while during infection, it was drawn to the vimentin cage 261 
area colocalizing with dsRNA (Fig. 5D). The cis-Golgi matrix protein GM130 was also found to 262 
redistribute from the typical perinuclear Golgi location towards vimentin organized cages 263 
(Fig. 5E). This process was partially prevented by IDPN treatment (Fig. 5E). 264 
 265 
Inhibition of vimentin dynamics leads to a marked decrease in non-structural protein 266 
expression as compared to viral structural proteins   267 
As the confocal microscopy suggested a clear difference between the expression and 268 
location of viral capsid proteins during IDPN treatment in comparison to 3D polymerase and 269 
2A protease, we set out to quantify the amounts of VP1 and different viral non-structural 270 
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proteins.  First of all, we observed that the VP1 expression was about 40 % lower than 271 
during normal infection (Fig. 6A). This was in line with the decrease seen in (+) strand 272 
synthesis (Fig. 4E).  In contrast, the signals for 2A, 3C and 3D were much lower when 273 
evaluated by western blotting (Fig. 6A). Quantification of all these non-structural proteins in 274 
comparison to VP1 detected in the same blots, revealed that all signals from non-structural 275 
proteins were markedly lower than VP1, approximately only about 20 %, 10% and 1% for 2A, 276 
3C and 3D from the amount of VP1, respectively (Fig. 6A).  This decrease coincided well with 277 
the lower activity of viral proteases 2A and 3C towards some of their cellular substrates (Fig. 278 
6B). The cellular substrate PABP and G3BP1 were left largely uncleaved despite of the 279 
infection taking place, thus leading to also higher cell viability (Fig. 6C). As these substrates 280 
have been linked to promotion of apoptosis during infection, we wanted to measure the 281 
effects of caspase activation.  Indeed, the lower activity towards PABP and G3BP1 coincided 282 
with a marked decrease in caspase activation (Fig. 6D), further explaining the lack of CPE in 283 
IDPN treated infected cells.  284 
Interestingly, the cellular substrate of 2A, the elF4G, was rather efficiently cleaved, albeit 285 
with lower efficiency when compared to control infection (Fig. 6E). As elF4G is linked to the 286 
host cell shutoff during viral infection, we evaluated the overall status of protein translation 287 
using metabolic labeling and observed a clear host cell shutoff both during normal infection 288 
and IDPN treatment (Fig. 6F). It thus seems that the minor effect of IDPN on elF4G via 2A 289 
allowed still a rather efficient host cell shutoff and efficient production of viral structural 290 
proteins during IDPN treatment. 291 
Cell killing during virus infection may also occur via ER stress. To rule out that the prolonged 292 
viability and lower cell killing during IDPN treatment had to do with ER stress response, we 293 
set out to monitor different ER stress markers and their expression (Fig. 6G). Tunicamycin 294 
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treatment (24 h) was used as a positive control. CVB3-infected cells with or without IDPN 295 
treatment did not show any similarities with tunicamycin treatment or changes in any of 296 
these marker proteins, indicating that ER stress was not induced in CVB3-mediated cell 297 
death (Fig. 6G). Reactive oxygen species (ROS) have also been associated with vimentin 298 
changes in the cells during stressful conditions. However, as we looked at the H2O2 299 
induction in the cells with the aid of the ROS-Glo kit (Promega), we could only observe 300 
minor changes in CVB3 treated cells when compared to the control cells either with or 301 
without IDPN treatment (Fig. 6H).   302 
These results altogether suggest that when vimentin dynamics are inhibited, cell killing is 303 
postponed due to low expression and activity of the non-structural viral proteases 2A and 304 
3C and not via ER stress or ROS production.  305 
 306 
Inhibiting vimentin dynamics slows down synthesis of especially non-structural proteins 307 
but does not accelerate degradation 308 
According to our results, the lower amount of non-structural proteins seemed to be a key 309 
aspect mediating the prolonged viability and reduced cell killing during IDPN treatment. Our 310 
results further indicated that during IDPN treatment there is also a marked reduction in 311 
non-structural -protein expression versus structural proteins. Therefore, a crucial question 312 
to be addressed was whether the non-structural proteins are actively down-regulated or 313 
inefficiently synthetized or processed. EV polyprotein is synthetized as one unit that is then 314 
cleaved and processed into the individual structural and non-structural proteins.  We first 315 
set out to define whether lower amounts of non-structural proteins is due to active 316 
degradation of those proteins. Western blot and VP1 immunostaining was performed from 317 
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samples taken at different timepoints during infection, with and without IDPN (Fig. 7A). The 318 
results showed that during normal infection the non-structural proteins 2A and 3D became 319 
visible after 4 and 5 h p.i. while VP1 was evident already earlier, starting from 3 h p.i. IDPN 320 
treatment caused lower synthesis of the VP1 and a delay in the appearance of VP1. In the 321 
same blot, 2A and 3D remained undetectable throughout the infection period.  As 322 
proteasomal degradation is the main mechanism to get rid of cytoplasmic proteins, we first 323 
used the specific proteasomal inhibitor, bortezomib, to assess the levels of VP1 and 2A 324 
during viral infection with and without IDPN. The western blotting results first of all 325 
confirmed our earlier observation that VP1 was moderately down-regulated during IDPN 326 
treatment, whereas 2A was almost non-detectable after 5.5 h p.i. (Fig. 7B, blot on the right, 327 
lanes 1 and 2).  Addition of bortezomib together with IDPN did not restore normal levels of 328 
VP1 or 2A, whereas they stayed similar to IDPN treatment alone, suggesting that the lower 329 
expression was not due to proteasomal degradation (Fig 7B, lanes 2, 5 and 6). This result 330 
was also confirmed with another proteasomal inhibitor lactacystin (data not shown).  331 
We also tested the involvement of cytoplasmic neutral proteases, calpains. Calpains are 332 
ubiquitous proteases readily available in the cytoplasm and shown to be involved in 333 
promoting enterovirus infection by us and others (46-48). Addition of calpain inhibitor 1 334 
around 2 h p.i. caused a more pronounced inhibition on VP1 than by mere IDPN treatment 335 
(Fig. 7B, lanes 2 and 3). Addition of calpain inhibitor 1 on top of IDPN treatment totally 336 
abolished viral protein production and infection (Fig. 7B, lane 4). Our recent results have 337 
shown that calpain proteases can contribute to efficient cleavage and maturation of 338 
structural proteins from the P1 region of the polyprotein (Laajala et al., unpublished). 339 
Therefore, the additive effect of calpains with IDPN to totally block both structural and non-340 
structural proteins was expected.  341 
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Western blot results also confirmed that the chaperone Hsp70 inhibitor VER155008 almost 342 
completely shuts down viral protein synthesis (Fig. 7B, lane 10). Hsp90 inhibitor 343 
Geldanamycin, on the other hand, had almost an opposite effect for viral protein synthesis 344 
in comparison to IDPN treatment: non-structural protein 2A was expressed in higher 345 
amounts than in IDPN treatment, whereas VP1 was found in lower amount (Fig. 7B, lanes 2 346 
and 11). 347 
The results altogether confirmed that the changes in vimentin cage formation causes a 348 
much higher reduction in synthesis of non-structural proteins in comparison to structural 349 
proteins.  The results further show that the effect is not executed via increased degradation 350 
of viral proteins. 351 
 352 
 353 
354 
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DISCUSSION  355 
Several viruses have been shown to cause changes in the cellular vimentin network during 356 
infection. There are several postulations on the role of vimentin dynamics, but no consensus 357 
has been found so far for the mechanisms of action. Vimentin aggregating or collapsing to 358 
make a perinuclear compartment has been previously reported with the closely related 359 
viruses enterovirus 71 and Foot- and-mouth disease virus (20), but also for less closely 360 
related viruses such as vaccinia virus (18), iridovirus (25), bluetongue virus (23), parvovirus 361 
(30, 31), African swine fever virus (34),  Epstein-Bar virus (19), and dengue virus (16, 29, 32, 362 
49, 50). These aggregates have been shown to surround the replicating DNA (18), dsRNA 363 
(16), non-structural or newly synthetized structural proteins (16, 20, 23, 29, 32), leading the 364 
authors to suggest that vimentin acts to surround the replication and assembly sites and to 365 
have a scaffolding or a protective role. Similarly, in our studies, the hallmark of these virus-366 
induced vimentin structures was the cage formation to surround the replication 367 
intermediate dsRNA. However, as vimentin rearrangements also led to ER and Golgi 368 
rearrangements, it could be postulated that the dsRNA was concentrating inside these 369 
vimentin structures by the redistribution of the ER and Golgi, which provides membranes 370 
for the replication processes. In fact, when the formation of these vimentin structures was 371 
inhibited, replication and progeny virus production continued, but dsRNA, NS-proteins and 372 
ER were more diffusely located around the cell. Translocation of the ER has been previously 373 
reported also for dengue virus infection (16). Although the presence of dsRNA or other 374 
replication elements within these structures was a constant feature in previously published 375 
studies, our results here show that the clustering of replication-associated structures inside 376 
the vimentin cage is not a necessary factor for infection and production for progeny viruses.  377 
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Our studies show that the formation of vimentin structures was dependent on viral protein 378 
translation based on several lines of evidence: 1) Cage formation was inhibited when either 379 
UV-inactivated or light-inactivated (neutral red treated) replication-incompetent viruses 380 
were used. 2) The structures were not seen when cells were transfected with a dsRNA 381 
analog or when infected cells were treated with protein synthesis inhibitors. Finally, 3) the 382 
appearance of the structures coincided with the time of viral protein synthesis and could be 383 
inhibited by perturbing the function of Hsp70, which efficiently blocked viral protein 384 
synthesis (9). Taking this into consideration, we were surprised to see that none of the ER 385 
stress markers were upregulated during infection. 386 
Vimentin has been previously shown to protect Hepatitis C virus core protein and the 387 
cellular protein Scrib from host mediated proteasomal degradation (15) (51). Proteasomal 388 
degradation of hepatitis C virus core protein was inhibited by MG-132, an inhibitor of 389 
proteasomal and calpain degradation. In our experiments MG-132 efficiently inhibited virus 390 
infection (data not shown) because of the strong dependence of enterovirus infection on 391 
calpain proteases ((48), Laajala et al, unpublished). MG-132 is a strong inhibitor of calpains 392 
and therefore, in our study, more specific inhibitors of proteasomal degradation was used, 393 
e.g. bortezomib and lactacystin. Those studies showed clearly that proteasomal degradation 394 
was not involved in IDPN induced effects. 395 
In addition to rapid life cycle and clear cytopathic effect, also the ability to cease host cell 396 
protein synthesis is a hallmark of enterovirus infection. Enteroviral host cell shut off and the 397 
onset of host cell apoptosis have been linked to the actions of the viral proteases 2A and 3C. 398 
Enteroviruses commonly have three viral proteases, which are in charge of viral polyprotein 399 
processing and cleavage of cellular targets (52). Protease 3CD is involved in the cleavage of 400 
P1 leading to the maturation of the capsid proteins VP1, VP2 and VP0. Pro 2A is believed to 401 
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autocatalytically cleave P1 from P2 while 3C and 3CD are supposed to take care of other 402 
polyprotein cleavages. In our results, we could observe low amounts of 3D, 3C and 2A 403 
expression with IDPN treatment by immunoblotting and immunofluorescence staining. Still, 404 
VP1 was observed in rather high amounts and, surprisingly, normal amounts of infectious 405 
particles were generated during IDPN treatment. We have unpublished information that 406 
calpain proteases 1 and 2 are able to correctly cleave capsid proteins from P1 (Laajala et al. 407 
unpublished). Thus, the ubiquitously present calpain proteases in the cytoplasm could 408 
contribute to capsid protein processing and explain the almost normal amounts of VP1 409 
during IDPN treatment with lower 3C and 3CD expression. It seems that the low amount of 410 
2A observed during IDPN treatment is enough to efficiently execute the cleavage of P1 out 411 
of P2-P3. Also, low amount of 3D polymerase was observed, which clearly produced enough 412 
RNA for the assembly of infectious viral particles.  413 
  414 
The cellular targets of 2A and 3C, PABP and G3BP1 are partially responsible for the host cell 415 
shut-off. Therefore, it was a surprise that, despite of their low amounts, virus infection was 416 
accompanied by a rather efficient host-cell-shutoff. From the cellular targets, the eIF4G 417 
cleavage was the least affected, and thus perhaps being responsible for the strong reduction 418 
of host cell protein production. During IDPN treatment, ample RNA and structural proteins 419 
were still produced during the first 6 hours of infection. Still, the high virus yields was 420 
somewhat unexpected because of the detected lower amounts of non-structural proteins. It 421 
is however likely that at later time points the virus yields are bound to get lower.  Rather 422 
than affecting the virus yields or host-cell-shutoff, the more important consequence of the 423 
lowered synthesis of the 2A and 3C/3CD was the reduced caspase activation. Caspase 3/7 424 
activation was clearly compromised leading to higher viability, while the viral protein and 425 
RNA production continued almost in a normal pace.  426 
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Our findings show that human enterovirus infection leads to massive vimentin 427 
rearrangements that harbor the replication site, as was indicated by the higher association 428 
of dsRNA, 2A and 3D polymerase with the vimentin cages. Many RNA viruses, including 429 
enteroviruses, have been shown to cause massive membrane rearrangements in the host 430 
cell during replication. The formation of these replication organelles have been shown to be 431 
caused by the viral non-structural proteins such as 3A (53). The replication organelles 432 
appear first as single membrane tubular structures, which evolve into double-membrane 433 
vesicles, which serve as platforms for replication (54, 55). Since both the time of appearance 434 
and localization into perinuclear area coincides for replication organelles and vimentin cage 435 
(54, 55), vimentin is likely to have a role in the formation or support of the replication area. 436 
In addition, when the vimentin dynamics were prevented, the replication area was more 437 
spread out, further suggesting that vimentin contributes to the organization of the 438 
replication area. Moreover, it can be speculated that the sequestration of replication area 439 
into vimentin cage may protect the virus from e.g. pattern recognition receptors (PRRs) of 440 
the host. These PRRs are part of the innate immune system and protect the host from 441 
pathogens by recognizing foreign molecules such as dsRNA (56). However, whether 442 
vimentin cage protects enteroviruses against innate immune response of the host cell, 443 
remains to be shown.  444 
Importantly, we also observed that the replication sites did not particularly accumulate 445 
structural proteins such as VP1, which was widely distributed around the cell and was thus 446 
less affected by the IDPN treatment. Instead, the inhibition of these structures reduced the 447 
synthesis levels of 2A, 3C and 3D and processing rather than their selective degradation. The 448 
results thus indicated that, due to IDPN treatment, cleavage products of P1 and P2 (VP1 and 449 
2A, respectively) were produced in different ratios. It has been shown that the processing of 450 
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P1 out from the polyprotein occurs co-translationally, when 2A rapidly cleaves between 451 
itself and VP1 as soon as the required components have been translated (57, 58). In the light 452 
of our results, perhaps the synthesis of the rest of the polyprotein (P2-P3) is then dependent 453 
on vimentin dynamics and takes place efficiently only if vimentin is specifically arranged. 454 
However, it will be important to study the true mechanistic basis behind these phenomena 455 
in the future. Speculatively, one explanation could be the various non-canonical translation 456 
pathways that RNA viruses use to translate multitude of proteins from their compact mRNA 457 
(59). Many RNA-viruses use non-canonical translation such as ribosomal frameshifting in 458 
order to regulate the ratios of different viral proteins, most commonly allowing greater 459 
production of structural proteins (60, 61), among those also cardiovirus and FMDV from the 460 
picornavirus family (62, 63). Whether such mechanisms are contributing to the observed 461 
different ratios of non-structural and structural protein synthesis and processing for CVB3 as 462 
well remains to be shown. 463 
Interestingly, Hsp90 inhibitor geldanamycin caused an arrest in VP1 production, while the 464 
effect in non-structural proteins was much milder. Hsp90 is known to bind P1 and 465 
contribute to P1 processing (11, 44). Thus, results with Hsp90 also suggest that different 466 
cellular mechanisms may affect P1 and production of structural proteins in contrast to non-467 
structural proteins. Vimentin has been shown to co-immunoprecipitate 2C of the foot-and-468 
mouth disease virus, and they together organize replication sites for efficient infection (20).  469 
Influenza A virus viral ribonucleoprotein was also shown to be bound by vimentin in the 470 
cytoplasm and thus preventing it from entering the nucleus and rather downregulating the 471 
infection (64). Interestingly, Lawson and Semler (65) showed using metabolic labeling of 472 
poliovirus 1 that much of the P1 and structural proteins accumulate in the cytosolic soluble 473 
fraction although P1 also stays partially membrane bound. In contrast, most of the non-474 
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structural proteins as well as P2 and P3 associate with the membrane bound fraction, 475 
supposedly the replication structures. Their results suggested that P2 and P3 processing is 476 
active early in infection in vivo in the membranous fraction, but does not occur anymore 477 
when P2, 3CD and P3 later appear in the soluble fraction. In contrast, P1 is actively 478 
processed further in the soluble fraction for longer periods. These results suggest that the 479 
distribution of P2-P3 and their individual proteins in soluble cytosolic or membrane bound 480 
fraction largely determines their activity in polyprotein processing (Fig. 8). It seems likely 481 
that vimentin cage organizes the replication structures together with 2C and provides an 482 
optimal niche for the initial replication/translation to occur and to produce viral proteases 483 
2A, 3C and 3CD as well as 3D polymerase.  Without the cage formation, the replication area 484 
is less organized, and the synthesis of non-structural proteins is less efficient while VP1 485 
production occurs almost normally in the soluble fraction. However, it will be important to 486 
study in the future, which factors exactly trigger vimentin rearrangements and also reveal 487 
the molecular mechanism behind the cage formation. Although we showed the effect of 488 
vimentin rearrangements specifically during the infection of enterovirus B species, it is likely 489 
that also other enterovirus species (A, C, D) would show similar dependence on vimentin 490 
rearrangements, taking into account the similarity of replication process among different 491 
species. 492 
In conclusion, we show that viral protein synthesis during enterovirus infection induces 493 
formation of a vimentin enwrapped perinuclear compartment harboring replicating dsRNA 494 
and non-structural proteins 3D and 2A. In turn, inhibition of vimentin rearrangements leads 495 
to scattered distribution of non-structural proteins and their lower expression and activity. 496 
This leads to delayed onset of apoptosis and higher viability of the host cells. In contrast, 497 
location and expression level of structural proteins such as VP1 stays largely unchanged, 498 
promoting efficient virus production. Altogether these results show that vimentin dynamics, 499 
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taking place in the infected cells, regulate the non-structural protein synthesis, without 500 
compromising infection efficiency but affecting host cell survival. 501 
502 
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MATERIALS AND METHODS 503 
 504 
Cells. Human alveolar basal epithelial cell line A549 and human cervix adenocarcinoma cell 505 
line HeLa MZ we used for the experiments. The cell lines were obtained from American type 506 
cell culture (ATCC) and grown in humidified 5% (v/v) CO2 at 37°C in Dulbecco’s modified 507 
Eagle’s medium (DMEM, Invitrogen) supplemented with 5% to 10% fetal bovine serum (FBS) 508 
supplemented with Glutamax (Invitrogen) and penicillin and streptomycin (P/S).  509 
Viruses. EV1 (Farouk strain), CVA9 (Griggs strain), CVB1 (Conn5 strain) and CVB3 (Nancy 510 
strain) were obtained from ATCC and propagated in green monkey kidney (GMK) cells. The 511 
virus was released from infected GMKs by freeze-thawing and concentrated by 512 
centrifugation into a sucrose cushion. Infectivity of the produced virus stock was assayed 513 
with an endpoint titration and viruses were used in excess in order to quarantee efficient 514 
infection (MOI 65) in A549 cells. When ice binding was used, the pfu/ml is mentioned for 515 
each experiment. For all infection studies, the culture medium was supplemented with 1 to 516 
5 % FBS.  517 
End point dilution. The assay was carried out in GMK cells (ATCC) cultured in 96-well plate. 518 
Cells were infected with CVB3 by preparing a dilution series in MEM supplemented with 1% 519 
FBS and 1% GlutaMAX. After 3 days of infection at + 37 °C, the cells were stained for 10 min 520 
with 50 μl of crystal violet stain (8.3 mM crystal violet, 45 mM CaCl2, 10% ethanol, 18.5% 521 
formalin, and 35 mM Tris base). The excess stain was washed with water, and the infectivity 522 
was determined based on the number of dyed (non-infected) and non-dyed (infected) wells. 523 
The 50% tissue culture infective dose (TCID50) was calculated by comparing the number of 524 
infected and uninfected wells for eight replicates of the same virus concentration. The 525 
concentration at which half of the wells would be infected was extrapolated (TCID50). 526 
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Finally, the TCID50 value was multiplied by 0.7 to obtain the PFU/ml value. End-point 527 
dilution for NR-CVB3 was done after inactivating the virus with light for 10 min or keeping 528 
the virus in the dark as a control. 529 
Reagents. Cycloheximide, Puromycin, tunicamycin and VER-155008 were purchased from 530 
Sigma-Aldricht whereas caspase inhibitor Z-VAD-fmk, caspase glo 3/7 assay –kit, ROS activity 531 
and cell titer glo- cell viability kit were obtained from Promega. Other reagents included 532 
Annexin V (Abcam), IDPN (Alfa Aesar), staurosporin (Enzo), Calpain inhibitor I (Roche), 533 
Geldanamycin (Enzo), Bortezomib (LC laboratories) and GuHCl (Sigma).  534 
Immunolabeling. In all immunofluorescence and confocal microscopy studies, the cells were 535 
grown on coverslips and fixed with 3 to 4 % PFA-PBS. Permeabilization, when needed, was 536 
performed with 0.1-0.2% Triton X-100-PBS. All used antibodies were diluted in 3% BSA-PBS 537 
and cells were stained by using a standard protocol for immunofluorescence staining with 538 
appropriate antibodies. Fluorescent conjugated goat secondary antibodies against mouse or 539 
rabbit antibodies were from Life Technologies. The coverslips were mounted with ProLong 540 
Gold Antifade Reagent with DAPI (life technologies).  541 
SDS-PAGE and western blotting. Cell lysates were suspended in laemmli buffer containing 542 
mercaptoethanol. Samples were separated in 12 % SDS-polyacrylamide gel or in 4-20% 543 
miniprotean TGX stain free gel (Biorad) and electroblotted into polyvinylidene difluoride 544 
membrane (Millipore). Appropriate primary antibodies together with horseradish 545 
peroxidase conjugated secondary antibodies were used in immunoblotting. Bands were 546 
detected by supersignal chemiluminescence detection kit (Thermo Scientific) and developed 547 
into X-ray film or imaged with Chemidoc MP (Biorad). 548 
Antibodies. To detect CVA9, CVB1 and CVB3 either polyclonal rabbit antiserum against CVA 549 
and CVB (kindly provided by Roivainen et al) or monoclonal antibody against EVs (ncl-550 
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entero, clone 5-D8/1) (Novocastra) was used. For detection of EV1, rabbit antisera against 551 
purified EV1 (66) was used. Antibodies against the ER-stress markers were obtained from 552 
ER-stress antibody sampler kit (cell signaling technologies). Other antibodies were 553 
monoclonal (NCL-VIM-V9, Leica microsystems) and rabbit polyclonal antibody against 554 
vimentin (H-84) (Santa Cruz biotechnology Inc.) in addition to monoclonal antibody against 555 
dsRNA (J2, English & Scientific Consulting Kft). GM130 and PDI antibodies were from Abcam 556 
and G3BP1, PABP, eIF4G and GAPDH antibodies were from Santa Cruz. Antibody against 557 
beta-tubulin was from Cedarlane. Viral protease antibodies have been previously published 558 
(67). Antibody against 3D was a kind gift from Antonio Toniolo, (Università dell'Insubria, 559 
Italy). 560 
Transfection of Poly-IC. A549 cells were transfected with Poly-IC (Santa Cruz) using 561 
Lipofectamine 3000. The amount of Poly-IC was 1 ng/µl or 50 ng/µl and transfection was 562 
carried out according to the instructions by the manufacturer. Cells were fixed with 4% PFA 563 
after 2, 4 or 6 h post-transfection. As control, cells were treated with transfection reagents 564 
only with no poly-IC. 565 
RT-qPCR. CVB3 infected A549 cells were freeze-thawed three times and cell debris pelleted 566 
down at full speed with table top centrifuge. Viral RNA from the supernatant was extracted 567 
according to the instructions of the manufacturer using QiAmp viral RNA Mini Kit (Qiagen). 568 
Reverse transcription was carried out for positive or negative strand RNA using either 1.2 569 
µM antisense (5’-GAAACACGGACACCCAAAGTA) or sense (5’-CGGCCCCTGAATGCGGCTAA) 570 
primers, 20 U M-MLV reverse transcriptase (Promega), 4 U RNAsin ribonuclease inhibitor 571 
(Promega) and dNTPs (Promega). From the reverse transcription reaction mixture (40 µl), 5 572 
µl was taken for PCR reaction, which also contained Sybr green supermix (Biorad) and 600 573 
nM of each primers. PCR was performed using C1000 Touch Thermal cycler (CFX96 real-time 574 
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system; Biorad) and the amplification steps were as follows: 95°C for 10 min; 40 cycles of 575 
95°C for 15 s to 60 °C  for 1 min and final melt at 72 to 95°C, 1°C/5 s. The assay contained 576 
three replicates of each sample and also contained negative controls to confirm the 577 
specificity of the products. 578 
Metabolic labeling. A549 cells were infected with 4.43 x 108 PFU/ml of CVB3. The virus was 579 
bound on ice for 1 h, after which the excess virus was washed with PBS. 1.5% IDPN in DMEM 580 
supplemented with 1% FBS was added after ice binding. After addition of IDPN, it was 581 
present at all steps until the end of the experiment. The infection was allowed to proceed in 582 
+ 37 ᵒC for 4 h, after which the low methionine/cysteine medium supplemented with 583 
dialyzed 1% FBS was added on cells. After 30 min, 500 µCi/ml of [35S] methionine-cysteine 584 
was added before a 1 h pulse. Samples were run at 4-20% miniprotean TGX stain free gel 585 
(Biorad), after which the gel was fixed with 30% methanol, 10% acetic acid for 30 min. Next, 586 
the gel was treated with an autoradiography enhancer (Enlightning; PerkinElmer) for 30 587 
min. Finally, the gel was dried at +70°C for 2 h (Gel dryer 583; Bio-Rad) and the dried gel was 588 
subjected to autoradiography. 589 
UV-inactivated EV1. Previous experiments for UV inactivation of picornaviruses (68, 69) 590 
were used as a guide for the general settings. Viruses were irradiated with Sylvania UV-C 591 
lamp (Ultraviolet 8H, 630W, Japan) with the intensity of 1.8 mW/cm2 for 30s. Lamp 592 
intensity was calibrated with spectrophotometer.  593 
Neutral red CVB3. NR-CVB3 were produced in the presence of 10 μg/ml of NR (catalog 594 
number 101369; Merck). The virus was released after overnight infection by freeze-thawing 595 
the cells and harvested by centrifugation. During the experiment, cells were kept in dark 596 
except for light inactivation which was for 10 minutes. 597 
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Crystal violet experiment (CPE). The cells were washed with PBS to remove the detached 598 
cell. Remaining cells were stained with crystal violet stain (0.03 % wt/vol crystal violet; 2 % 599 
ethanol; 3 % formalin in water). The plate was incubated at RT for 10 min and the unbound 600 
stain removed. After washes with sterile water, lysis buffer (8.98 % wt/vol sodium citrate, 601 
125 mM HCl, 47.0 % EtOH) was added to the cells and absorbance was measured from the 602 
homogenized solution at wavelength 570 nm using Victor microplate reader.  603 
Imaging and analysis. Samples were imaged with Olympus FV1000-IX81 or Zeiss LSM700 604 
confocal microscopes. Appropriate excitation and emission settings were used (405-nm 605 
diode laser, 488-nm argon laser and 543-nm HeNe-laser). 60x UPLSAPO objective (NA 1.35) 606 
and 20x/0.5 EC Plan-Neofluar objective with resolution of 512×512 or 640x640 pixels/image 607 
were used. Levels for the laser power, detector amplification, and optical sections were 608 
optimized for each channel before starting the imaging. The threshold for each channel was 609 
adjusted to separate the signal from noise and data from the images was quantified using a 610 
free, open source software package, BioImageXD (70). In order to quantitate the relative 611 
amount of antigen per cell, the total intensity was divided with DAPI-stained nucleus volume 612 
or with the total intensity of another antigen to gain the ratio of different antigens. For 613 
quantification of fluorescent intensities and the relative amount of the immunolabeled 614 
antigen, at least 30 cells from three independent experiments were imaged unless 615 
otherwise stated. Quantification were done on single-section images taken from the center 616 
of the cell. 617 
Statistical analysis. Statistical analysis was performed with GraphPad Prism software. 618 
Statistical significance of pair wise differences was determined by student´s t-test.  All data 619 
is presented as mean ± SEM. 620 
 621 
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FIGURE LEGENDS 844 
 845 
Fig 1. Human enterovirus infection induces vimentin enwrapped dsRNA-harboring 846 
compartment to the perinuclear location in A549 cells. A549 cells were fixed, 847 
immunolabeled, and visualized with confocal microscopy. (A) Images from single sections 848 
showing vimentin (green) and virus capsid (magenta) in cells after CVB3 (5 h p.i.) infection. 849 
(B) Vimentin (green) and tubulin (magenta) network in non-infected (ctrl) and CVB3 infected 850 
(5 h p.i.) cells. Infected cells are marked with asterisk. (C) Images from single sections 851 
showing vimentin (green) and virus capsid (magenta) in cells after EV1 (6 h p.i.), CVB1 (6 h 852 
p.i.), and CVA9 (5h p.i.) infections. Non-infected cells are marked with asterisks. (D) 853 
Projection of Z-sections showing dsRNA (green) and vimentin (Magenta). Orthogonal 854 
sections providing a view of these structures in 3D after CVB3 infection (5 h p.i.). (E) Images 855 
of single sections showing vimentin structure formation from 2.5 h to 6h p.i. Cell boundaries 856 
drawn to visualize state of cell detachment.  857 
Fig 2. The appearance of VP1 and dsRNA coincide with vimentin rearrangements during 858 
CVB3 infection. A549 cells were fixed, immunolabeled, and visualized with confocal 859 
microscopy. (A) Single section images showing vimentin and VP1 (capsid) at different 860 
timepoints p.i. (B) Quantifications of confocal images taken at different time points during 861 
CVB3 infection. The results shown here are representations of at least three independent 862 
experiments. For the quantifications, approximately 200 cells altogether from two to three 863 
replicates were analyzed (+/-SEM). Scale bars 20µm      864 
Fig 3. Viral protein synthesis is essential for the vimentin cage formation. (A) Schematic 865 
illustration showing the principle of neutral red viruses (top). A549 cells infected with 866 
neutral red-CVB3 exposed to light treatment at different time points, and the presence of 867 
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virus-induced vimentin structures was visualized from single section confocal images and 868 
quantitated. For the quantifications, approximately 50 cells per sample of three replicates 869 
were analyzed. (B) Single section confocal images illustrating the effect of UV-inactivated 870 
EV1 on A549 cells at 6 h p.i.. Cells were immunolabeled for capsid (green) and vimentin 871 
(magenta) (C) Graphs showing the results of the CPE experiment in CVB3-infected A549 872 
after differential treatments with either cycloheximide (200 µg/ml) or puromycin (100 873 
µg/ml). Drugs were added to the cells at different time points p.i. and left until the end of 874 
the experiment (8h p.i.). Control cells were normalized to 100 %. Representative of at least 875 
two separate experiments with three replicate samples within each. (D) Single section 876 
confocal images visualizing vimentin (green) and virus capsids (red) in CVB3-infected (5 h 877 
p.i.) A549 cells with ctrl, puromycin (100 µg/ml) or cycloheximide (200 µg/ml) treatment 878 
when the drugs were introduced at 2 h p.i. Scale bars 20 µm. Representative of at least two 879 
separate experiments. (E) Western blot showing VP1 expression in infected cells after 880 
cycloheximide (200 µg/ml) or puromycin (100 µg/ml) treatments. The drugs were added at 2 881 
h p.i. and left until the end of the experiment (5.5 h p.i.). Representative of at least two 882 
separate experiments. (F)  RT-qPCR from CVB3 infected cells treated with or without 883 
cycloheximide (200 µg/ml) or puromycin (100 µg/ml). Virus (8.86 x 107 PFU/ml) was bound 884 
on cells on ice for 1 h. After washing excess virus, the infection was allowed to proceed for 885 
5.5 h. The drugs were added at 2 h p.i. and left until the end of the experiment. N/A, signal 886 
is below detection threshold. (G) Graph showing the results of the cell viability 887 
measurement (ATP) of CVB3-infected A549 after differential treatments with either 888 
VER155008 (50 µM) or geldanamycin (0.1 µM). Drugs were added to the cells together with 889 
the virus and left until the end of the experiment (10 h.). Representative of at least two 890 
separate experiments with three replicate samples within each. (H) The quantification of 891 
confocal images of CVB3-infected, VER155008 and Geldanamycin treated A549 cells 892 
 o
n
 D
ecem
ber 16, 2019 at TAM
PERE UNIVERSITY LIBRARY
http://jvi.asm.org/
D
ow
nloaded from
 
38 
 
 
showing virus-induced vimentin structures. Data was obtained from at least 100 cells from 893 
two independent experiments.  (I) Single section confocal images showing dsRNA (green) in 894 
CVB3 infected cells with or without VER155008 (50 µM) or geldanamycin (0.1 µM ) 895 
treatments. Virus (4.43 x 108 PFU/ml) was bound on ice for 1 h, and after washing excess 896 
virus, the infection was allowed to proceed for 5.5 h. The drugs were added after ice binding 897 
and left until the end of the experiment. Scale bars 20 µm. (J) Western blot showing VP1 898 
expression in infected cells after VER155008 (50 µM) or geldanamycin (0.1 µM) treatments. 899 
The drugs were added to the cells together with the virus and left until the end of the 900 
experiment (5.5 h p.i.). Representative of at least two separate experiments. 901 
Fig 4. IDPN treatment delays virus-induced cell death without compromising the 902 
production of progeny viruses. (A) Graph showing the effect of IDPN treatment on A549 cell 903 
viability. Representative of two replicates. (B) Single section images showing vimentin 904 
distribution after 5.5 h of 1.5% IDPN treatment. Representative of at least three separate 905 
experiments. (C) Graph showing cell viability (ATP) in CVB3 infected A549 cells with and 906 
without IDPN treatment (1.5 %). Drug was added together with the virus and kept until the 907 
end of the experiment. Representative of at least two separate experiments with three 908 
replicate samples within each. (D) End-point titration of progeny viruses produced after 6 h 909 
CVB3 infection in A549 cells with or without IDPN treatment. Representative of two 910 
independent experiments. (E) RT-qPCR from cells infected with CVB3 for 1, 3, 4 or 5 h with 911 
or without IDPN treatment. Virus (8.86 x 107 PFU/ml) was bound on cells on ice for 1 h. After 912 
washing excess virus, the infection was allowed to proceed for the indicated time. IDPN was 913 
added after ice binding and left until the end of the experiment. (F) Single section confocal 914 
images illustrating the effect of IDPN on replication (dsRNA, green) and vimentin (magenta). 915 
Representative image of at least three replicates. Scale bar 20 µm.   916 
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Fig 5. Vimentin cage preferentially hosts non-structural proteins. (A) Single sections 917 
showing location of 3D magenta or (B) 2A (magenta) in the perinuclear area and vimentin 918 
(green) in control or CVB3 infected cells with or without IDPN treatment. Virus (4.43 x 108 919 
PFU/ml) was bound on ice for 1 h. After washing the excess virus away, infection was 920 
allowed to proceed for 5.5 h. IDPN was added after ice binding and left until the end of the 921 
experiment. (C) Single sections showing the location of VP1 diffusely in the cytoplasm in 922 
CVB3 infected cells with or without IDPN treatment. Infection was carried out as described 923 
above in B. Scale bars 20 µm. Representative images of at least three separate experiments. 924 
(D) Single section confocal images illustrating the effect of IDPN on (D) ER (PDI) (5.5. h p.i) 925 
and (E) Golgi (GM130) (5.5 h p.i). Scale bar 20 µm. The images are representative of at least 926 
two separate experiments.   927 
Fig 6. Inhibition of vimentin dynamics affects the levels and activity of non-structural 928 
proteins. (A) Graphs showing quantifications of western blots where levels of VP1, 2A, 3C 929 
and 3D were detected in CVB3 infected A549 cells with or without IDPN treatment. Virus 930 
(4.43 x 108 PFU/ml) was bound on ice for 1 h. After washing the excess virus away, infection 931 
was allowed to proceed for 5.5 h. IDPN was added after ice binding and left until the end of 932 
the experiment. Band intensities were quantified using Image J and the quantifications were 933 
done from at least three separate experiments. (B) Western blots were immunolabeled with 934 
antibodies against PABP, G3BP1, VP1 and GAPDH. Arrowhead indicates CVB3 induced 935 
cleavage product. Representative of at least two separate experiments. (C) Graphs showing 936 
the results of the viability measurement (C) and caspase activity (D) per viable cell of A549 937 
cells treated with z-vad fmk (200µM) or IDPN (1.5%) with or without CVB3 infection. Drugs 938 
were added to the cells together with the virus and left until the end of the experiment (10 939 
and 24 h p.i.). Graphs are showing the results from three independent experiment. (E) 940 
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Western blots were immunolabeled with antibodies against eIF4G, VP1 and GAPDH. 941 
Representative of at least two separate experiments. (F) Pulse labeling of CVB3 infected 942 
cells with or without 1.5% IDPN treatment. Virus (4.43 x 108 PFU/ml) was bound on ice for 943 
1h after which the excess virus was washed away. IDPN was added after ice binding and left 944 
until the end of the experiment. Pulse labeling with radioactive Sulphur (500 µCi/ml) was 945 
carried out at 4.5-5.5 h p.i. Representative of two separate experiments. (G) 946 
Immunoblotting performed after SDS-PAGE showing the expression status of different ER 947 
markers with and without CVB3 (5.5 h p.i.) and/or IDPN in A549 cells. Tunicamycin (TM; 948 
5µg/ml) was used as a positive control and GAPDH as a loading control. (H) Luminescence 949 
measurement indicating the ROS activation in A549 cells without CVB3 (6 h p.i.) and/or 950 
IDPN. Graphs are showing the results from three independent experiment. (* = P <0.05). 951 
Fig 7. Vimentin dynamics affect the synthesis of non-structural proteins rather than their 952 
degradation. (A) Western blot of A549 cells infected with CVB3 for 3, 4, 5 or 6 h with or 953 
without IDPN treatment. Virus (4.43 x 108 PFU/ml) was bound on ice for 1h. After washing 954 
the excess virus away, infection was allowed to proceed for the indicated time. IDPN was 955 
added after ice binding and left until the end of the experiment.  eIF4G, 3D, 2A and VP1 956 
were visualized using antibodies against the proteins. Representative image of two 957 
replicates. (B) Western blot showing the effect of 1.5% IDPN, 7 µM bortezomib, 200 µM 958 
Calpain inhibitor 1, 100 µg/ml puromycin, 50 µM VER155008 or 0.1 µM geldanamycin on 959 
CVB3 infection. Virus (4.43 x 108 PFU/ml) was bound on ice for 1 h. After washing the excess 960 
virus away, infection was allowed to proceed for 5.5 h. Other drugs were added after ice 961 
binding except calpain inhibitor, bortezomib and puromycin, which were added at 2 h p.i. All 962 
drugs were left until the end of the experiment. Visualization of VP1 and P1 on the left. 963 
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Merged image of 2A and VP1 labelings on the right. Representative results of at least two 964 
separate experiments. 965 
Fig 8. Summary. Viral protein synthesis during enterovirus infection induces formation of a 966 
vimentin enwrapped perinuclear compartment harboring the viral non-structural proteins. 967 
Inhibition of vimentin rearrangements leads to scattered distribution of non-structural 968 
proteins and their lower expression and activity, without affecting the structural proteins 969 
and viral progeny production. Stars indicate the magnitude of the phenomenon. NS-970 
proteins, non-structural proteins. 971 
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